The clinical and economic benefits of capecitabine and tegafur with uracil in metastatic colorectal cancer.
Almond
J
J
Ralston
S
S
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000191:economics* / Q000627:therapeutic use*; D000069287:Capecitabine; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000191:economics* / Q000556:secondary; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use; D005472:Fluorouracil / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use; D005641:Tegafur / Q000191:economics / Q000627:therapeutic use*; D006113:United Kingdom; D014498:Uracil / Q000008:administration & dosage / Q000191:economics
D003841:Deoxycytidine; D005641:Tegafur; D014498:Uracil; D000069287:Capecitabine; D005472:Fluorouracil